Official source
Source domain: medicalschemes.co.za
Collected on 4 August 2026
Always confirm details on the official source before acting.
Read out of this document by Govermate's AI, in its own words. Each one quotes the line it came from — confirm on the official source before acting.
DTP code 260S for non-treatable HCC cases
For patients with HCC not treatable under PMB regulations, DTP code 260S may be applied based on clinical assessment. This covers comfort care, pain relief, and hydration for patients with imminent death regardless of diagnosis.
For those patients who are diagnosed with HCC that is not treatable according to the PMB Regulations, DTP code 260S may be applied dependent on the clinical case.
Reference
https://www.medicalschemes.co.za/cmscript-13-of-2021-hepatocellular-carcinoma/
PMB funding for treatable hepatocellular carcinoma (HCC)
Medical schemes must fund the diagnosis and treatment of treatable hepatocellular carcinoma under DTP code 950G. This includes all necessary tests and therapies qualifying as PMB-level care, as defined in the Council's guidelines.
As part of PMB level of care, medical schemes must fund the diagnosis and treatment of treatable Hepatocellular carcinoma HCC, which falls under DTP code 950G.
Prescribed Minimum Benefit Guidelines for Hepatocellular Carcinoma
The Council for Medical Schemes has published detailed guidelines specifying which tests and treatments qualify as PMB-level care for HCC, helping healthcare providers and schemes determine eligibility.
The Council for Medical Schemes has published the Prescribed Minimum Benefit Guidelines for Hepatocellular c arcinoma (HCC) , and these provide detailed information on which tests and treatment options are PMB level of care and which ones are not.
